董事介绍
注:董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Kevin A. Lobo | 男 | Chair, Chief Executive Officer and President | 60 | 2197.94万美元 | 10.07 | 2026-01-01 |
| Rajeev Suri | 男 | Director | 58 | 34.04万美元 | 0.52 | 2026-01-01 |
| Lisa M. Skeete Tatum | -- | Director | 58 | 34.04万美元 | 0.22 | 2026-01-01 |
| Rachel M. Ruggeri | -- | Director | -- | 29.76万美元 | 0.0026 | 2026-01-01 |
| Emmanuel P. Maceda | -- | Director | 63 | 未披露 | 未持股 | 2026-01-01 |
| Mary K. Brainerd | -- | Director | 71 | 35.86万美元 | 0.58 | 2026-01-01 |
| Andrew K. Silvernail | 男 | Director | 54 | 36.36万美元 | 0.79 | 2026-01-01 |
| Ronda E. Stryker | 女 | Director | 71 | 34.04万美元 | 1743.48 | 2026-01-01 |
| Giovanni Caforio | 女 | Director | 61 | 34.04万美元 | 0.22 | 2026-01-01 |
| Sherilyn S. McCoy | 女 | Lead Independent Director | 67 | 38.04万美元 | 0.08 | 2026-01-01 |
高管介绍
注:高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Kevin A. Lobo | 男 | Chair, Chief Executive Officer and President | 60 | 2197.94万美元 | 10.07 | 2026-01-01 |
| William E. Berry Jr. | 男 | Vice President, Chief Accounting Officer | 60 | 未披露 | 未持股 | 2026-01-01 |
| Yin C. Becker | 女 | Vice President, Chief Corporate Affairs Officer | 62 | 未披露 | 未持股 | 2026-01-01 |
| M. Kathryn Fink | 女 | Vice President, Chief Human Resources Officer | 56 | 未披露 | 未持股 | 2026-01-01 |
| Viju Menon | -- | Group President, Global Quality and Operations | 58 | 458.95万美元 | 0.92 | 2026-01-01 |
| Robert S. Fletcher | -- | Vice President, Chief Legal Officer | 55 | 223.67万美元 | 未持股 | 2026-01-01 |
| J. Andrew Pierce | -- | President, Medical Surgery and Neurotechnology Group | 52 | 675.93万美元 | 6.21 | 2026-01-01 |
| Spencer S. Stiles | -- | President and Chief Operating Officer | 49 | 675.93万美元 | 5.70 | 2026-01-01 |
| Preston W. Wells | 男 | Vice President, Chief Financial Officer | 49 | 未披露 | 未持股 | 2026-01-01 |
| Dylan Crotty | 男 | Group President, Orthopaedics | 49 | 未披露 | 未持股 | 2026-01-01 |
董事简历
中英对照 |  中文 |  英文- Kevin A. Lobo
-
Kevin A. Lobo,自2014年7月起担任Stryker Corporation(医疗技术)董事会主席,自2012年10月起担任首席执行官、总裁兼董事。此前,他曾担任Stryker的骨科、神经技术和脊柱集团总裁。Lobo曾担任上述高级领导职务,并在全球公司(包括公开交易的医疗技术和消费品公司)担任其他各种上市公司的领导职务。
Kevin A. Lobo,has been Chairman of the Board of Stryker Corporation (medical technologies) since July 2014 and has been Chief Executive Officer, President and a Director since October 2012. He previously served as Group President for Stryker's Orthopedics and Neurotechnology and Spine Groups.Mr. Lobo has held the senior leadership positions noted above and other various public company leadership roles in global companies, including publicly traded medical technology and consumer products companies. - Kevin A. Lobo,自2014年7月起担任Stryker Corporation(医疗技术)董事会主席,自2012年10月起担任首席执行官、总裁兼董事。此前,他曾担任Stryker的骨科、神经技术和脊柱集团总裁。Lobo曾担任上述高级领导职务,并在全球公司(包括公开交易的医疗技术和消费品公司)担任其他各种上市公司的领导职务。
- Kevin A. Lobo,has been Chairman of the Board of Stryker Corporation (medical technologies) since July 2014 and has been Chief Executive Officer, President and a Director since October 2012. He previously served as Group President for Stryker's Orthopedics and Neurotechnology and Spine Groups.Mr. Lobo has held the senior leadership positions noted above and other various public company leadership roles in global companies, including publicly traded medical technology and consumer products companies.
- Rajeev Suri
-
Rajeev Suri担任诺基亚公司(Nokia)的总裁兼首席执行官。他从2014年开始担任诺基亚集团(Nokia Group)的领导团队成员和主席。他于1995年加入诺基亚公司。在印度卡纳塔克邦的印度门戈洛尔大学(Mangalore University)曼尼帕尔理工学院(Manipal Institute of Technology)获得电子学和通信学的工程学士学位。从2009年至2014年,担任NSN的首席执行官。从2007年至2009年,担任NSN的服务部主管。于2007年担任NSN的亚太地区负责人。从2005年至2007年,担任诺基亚网络公司(Nokia Networks)亚太地区的高级副总裁。从2004年至2005年,担任诺基亚网络公司的哈奇森客户业务团队的副总裁。于2003年担任诺基亚网络公司亚太地区的业务开发部的总经理。于2002年担任诺基亚网络公司的BT、O2和哈奇森全球客户部的销售总监。从2000年至2001年,担任诺基亚网络公司的BT全球客户部、技术和应用部的总监。从1999年至2000年,担任诺基亚网络公司的全球竞争情报部的主管。从1997年至1999年,担任诺基亚网络公司南亚地区的产品能力部主管。从1995年至1997年,担任诺基亚网络公司印度地区的蜂窝传输部的系统营销经理。从1993年至1995年,尼日利亚彻克盖特事业部的集团采购、进口和特殊项目部的主管。从1990年至1993年,担任ICL India ICIM的传输部全国客户经理与战略规划部经理。于1989年担任Calcom Electronics的生产工程师。
Rajeev Suri,Chief Executive Officer and Director, Inmarsat (2021-2023);President and Chief Executive Officer, Nokia (2014-2020); Chief Executive Officer, Nokia Solutions and Networks (2009-2014);Various leadership roles with Nokia (1995-2009).Other Affiliations:Chairman of the Board, Digicel Group;Director, Singtel;Director, Viasat. - Rajeev Suri担任诺基亚公司(Nokia)的总裁兼首席执行官。他从2014年开始担任诺基亚集团(Nokia Group)的领导团队成员和主席。他于1995年加入诺基亚公司。在印度卡纳塔克邦的印度门戈洛尔大学(Mangalore University)曼尼帕尔理工学院(Manipal Institute of Technology)获得电子学和通信学的工程学士学位。从2009年至2014年,担任NSN的首席执行官。从2007年至2009年,担任NSN的服务部主管。于2007年担任NSN的亚太地区负责人。从2005年至2007年,担任诺基亚网络公司(Nokia Networks)亚太地区的高级副总裁。从2004年至2005年,担任诺基亚网络公司的哈奇森客户业务团队的副总裁。于2003年担任诺基亚网络公司亚太地区的业务开发部的总经理。于2002年担任诺基亚网络公司的BT、O2和哈奇森全球客户部的销售总监。从2000年至2001年,担任诺基亚网络公司的BT全球客户部、技术和应用部的总监。从1999年至2000年,担任诺基亚网络公司的全球竞争情报部的主管。从1997年至1999年,担任诺基亚网络公司南亚地区的产品能力部主管。从1995年至1997年,担任诺基亚网络公司印度地区的蜂窝传输部的系统营销经理。从1993年至1995年,尼日利亚彻克盖特事业部的集团采购、进口和特殊项目部的主管。从1990年至1993年,担任ICL India ICIM的传输部全国客户经理与战略规划部经理。于1989年担任Calcom Electronics的生产工程师。
- Rajeev Suri,Chief Executive Officer and Director, Inmarsat (2021-2023);President and Chief Executive Officer, Nokia (2014-2020); Chief Executive Officer, Nokia Solutions and Networks (2009-2014);Various leadership roles with Nokia (1995-2009).Other Affiliations:Chairman of the Board, Digicel Group;Director, Singtel;Director, Viasat.
- Lisa M. Skeete Tatum
-
Lisa M. Skeete Tatum, 2014年至今,担任Cardinal Partners的普通合伙人(2004-2014年),STI, Inc.的创始人(1995-1998年),担任Procter and Gamble的各种全球职能职务(1989-1994年)。关键技能和经验:医疗保健行业,技术/数字,金融。其他单位:联合广场酒店集团董事会成员,USHG收购公司董事。
Lisa M. Skeete Tatum,Founder and Chief Executive Officer, Landit, Inc. (2014-present);Angel and Fund Investor (2010-2014);General Partner, Cardinal Partners (1998-2009);Founder, STI, Inc. (1995-1998);Various global and functional roles with Procter and Gamble (1989-1994).Board Member, Union Square Hospitality Group;Director, USHG Acquisition Corporation (2021-2022);Director, World 50, Inc.;Trustee Emeritus, Cornell University. - Lisa M. Skeete Tatum, 2014年至今,担任Cardinal Partners的普通合伙人(2004-2014年),STI, Inc.的创始人(1995-1998年),担任Procter and Gamble的各种全球职能职务(1989-1994年)。关键技能和经验:医疗保健行业,技术/数字,金融。其他单位:联合广场酒店集团董事会成员,USHG收购公司董事。
- Lisa M. Skeete Tatum,Founder and Chief Executive Officer, Landit, Inc. (2014-present);Angel and Fund Investor (2010-2014);General Partner, Cardinal Partners (1998-2009);Founder, STI, Inc. (1995-1998);Various global and functional roles with Procter and Gamble (1989-1994).Board Member, Union Square Hospitality Group;Director, USHG Acquisition Corporation (2021-2022);Director, World 50, Inc.;Trustee Emeritus, Cornell University.
- Rachel M. Ruggeri
-
暂无中文简介
暂无英文简介 -
暂无中文简介
- 暂无英文简介
- Emmanuel P. Maceda
-
Emmanuel P. Maceda,Bain公司主席(2025年1月至今);Bain公司全球管理合伙人兼首席执行官(2018-2024年);在Bain公司担任各种领导职务(1989-2018年)。
Emmanuel P. Maceda,Chair, Bain & Company (January 2025-present);Worldwide Managing Partner and CEO, Bain & Company (2018-2024);Various leadership roles with Bain & Company (1989-2018). - Emmanuel P. Maceda,Bain公司主席(2025年1月至今);Bain公司全球管理合伙人兼首席执行官(2018-2024年);在Bain公司担任各种领导职务(1989-2018年)。
- Emmanuel P. Maceda,Chair, Bain & Company (January 2025-present);Worldwide Managing Partner and CEO, Bain & Company (2018-2024);Various leadership roles with Bain & Company (1989-2018).
- Mary K. Brainerd
-
Mary K. Brainerd,担任HealthPartners的总裁兼首席执行官(2002-2017),在HealthPartners担任各种领导职务(1992-2002),在明尼苏达州蓝十字和蓝shield担任各种领导职务(1984-1992)其他从属关系:Bremer Financial Corporation董事,Securian Financial董事,明尼苏达州-北达科他州-南达科他州自然保护协会主席,Opus Group董事,Stryker董事会委员会,薪酬和人力资本,治理和提名。
Mary K. Brainerd,President and Chief Executive Officer of HealthPartners (2002-2017);Various leadership roles with HealthPartners (1992-2002);Various leadership roles with Blue Cross and Blue Shield of Minnesota (1984-1992)Other Affiliations:Director, Bremer Financial Corporation;Director, Securian Financial;Chair, The Nature Conservancy, Minnesota-North Dakota-South Dakota;Director, The Opus Group:Stryker Board Committees;Compensation and Human Capital;Governance and Nominating. - Mary K. Brainerd,担任HealthPartners的总裁兼首席执行官(2002-2017),在HealthPartners担任各种领导职务(1992-2002),在明尼苏达州蓝十字和蓝shield担任各种领导职务(1984-1992)其他从属关系:Bremer Financial Corporation董事,Securian Financial董事,明尼苏达州-北达科他州-南达科他州自然保护协会主席,Opus Group董事,Stryker董事会委员会,薪酬和人力资本,治理和提名。
- Mary K. Brainerd,President and Chief Executive Officer of HealthPartners (2002-2017);Various leadership roles with HealthPartners (1992-2002);Various leadership roles with Blue Cross and Blue Shield of Minnesota (1984-1992)Other Affiliations:Director, Bremer Financial Corporation;Director, Securian Financial;Chair, The Nature Conservancy, Minnesota-North Dakota-South Dakota;Director, The Opus Group:Stryker Board Committees;Compensation and Human Capital;Governance and Nominating.
- Andrew K. Silvernail
-
Andrew K. Silvernail,于2024年5月1日加入国际纸业担任首席执行官,并于2024年10月1日成为国际纸业董事会主席。Silvernail先生在领导制造业和技术领域的全球公司方面拥有二十年的经验。他从全球投资公司KKR & Co.,Inc.加入IP,曾担任执行顾问,以及5 Nails,LLC,一家私人投资咨询公司,曾担任创始人、董事长兼首席执行官(2022-2024年)。Silvernail先生曾担任Madison Industries的董事长兼首席执行官,Madison Industries是世界上最大的私营公司之一(2021年)。在此之前,Silvernail曾担任IDEX公司(NYSE:IEX)的董事长兼首席执行官(2011-2020年)。Silvernail先生此前曾在Rexnord Industries、Newell Rubbermaid(NASDAQ:NWL)和丹纳赫公司(NYSE:DHR)担任高管职务。他在史赛克公司(NYSE:SYK)和Potter Global Technologies(一家专门从事消防和安全解决方案的私营公司)的董事会任职。
Andrew K. Silvernail,joined International Paper as chief executive officer on May 1, 2024, and became chairman of the International Paper Board on October 1, 2024. Mr. Silvernail has two decades of experience leading global companies in the manufacturing and technology sectors. He joined IP from KKR & Co., Inc., a global investment firm, where he served as an executive advisor, and 5 Nails, LLC, a private investment advisory firm where he served as founder, chair and chief executive officer (2022-2024). Mr. Silvernail served as the chairman and chief executive officer of Madison Industries, one of the world's largest privately held companies that owns and operates businesses across various sectors including filtration, medical and energy (2021). Prior to that, Mr. Silvernail served as chairman and chief executive officer of IDEX Corporation (NYSE: IEX) (2011-2020). Mr. Silvernail previously held executive positions at Rexnord Industries, Newell Rubbermaid (NASDAQ: NWL) and Danaher Corporation (NYSE: DHR). - Andrew K. Silvernail,于2024年5月1日加入国际纸业担任首席执行官,并于2024年10月1日成为国际纸业董事会主席。Silvernail先生在领导制造业和技术领域的全球公司方面拥有二十年的经验。他从全球投资公司KKR & Co.,Inc.加入IP,曾担任执行顾问,以及5 Nails,LLC,一家私人投资咨询公司,曾担任创始人、董事长兼首席执行官(2022-2024年)。Silvernail先生曾担任Madison Industries的董事长兼首席执行官,Madison Industries是世界上最大的私营公司之一(2021年)。在此之前,Silvernail曾担任IDEX公司(NYSE:IEX)的董事长兼首席执行官(2011-2020年)。Silvernail先生此前曾在Rexnord Industries、Newell Rubbermaid(NASDAQ:NWL)和丹纳赫公司(NYSE:DHR)担任高管职务。他在史赛克公司(NYSE:SYK)和Potter Global Technologies(一家专门从事消防和安全解决方案的私营公司)的董事会任职。
- Andrew K. Silvernail,joined International Paper as chief executive officer on May 1, 2024, and became chairman of the International Paper Board on October 1, 2024. Mr. Silvernail has two decades of experience leading global companies in the manufacturing and technology sectors. He joined IP from KKR & Co., Inc., a global investment firm, where he served as an executive advisor, and 5 Nails, LLC, a private investment advisory firm where he served as founder, chair and chief executive officer (2022-2024). Mr. Silvernail served as the chairman and chief executive officer of Madison Industries, one of the world's largest privately held companies that owns and operates businesses across various sectors including filtration, medical and energy (2021). Prior to that, Mr. Silvernail served as chairman and chief executive officer of IDEX Corporation (NYSE: IEX) (2011-2020). Mr. Silvernail previously held executive positions at Rexnord Industries, Newell Rubbermaid (NASDAQ: NWL) and Danaher Corporation (NYSE: DHR).
- Ronda E. Stryker
-
Ronda E. Stryker是本公司的创办人孙女及本公司前总裁的女儿。她也是绿叶信托银行Spelman学院和卡拉马祖学院的副主席,卡拉马祖社区基金会副会长及受托董事。
Ronda E. Stryker,Director of Stryker Corporation for 40 years;Vice Chair and Director, Greenleaf Trust (1988-present).Other Affiliations:Vice Chair, Spelman College Board of Trustees;Member, Harvard Medical School Board of Fellows.Stryker Board Committees:Governance and Nominating. - Ronda E. Stryker是本公司的创办人孙女及本公司前总裁的女儿。她也是绿叶信托银行Spelman学院和卡拉马祖学院的副主席,卡拉马祖社区基金会副会长及受托董事。
- Ronda E. Stryker,Director of Stryker Corporation for 40 years;Vice Chair and Director, Greenleaf Trust (1988-present).Other Affiliations:Vice Chair, Spelman College Board of Trustees;Member, Harvard Medical School Board of Fellows.Stryker Board Committees:Governance and Nominating.
- Giovanni Caforio
-
Giovanni Caforio,百时美施贵宝首席执行官(2015-2023);董事会主席(2017年至今);Bristol-Myers Squibb的各种领导职务(2000年至2015年)。其他职务:美国制药研究和制造商协会董事。Stryker Corporation董事会委员会:薪酬和人力资本;治理和提名。
Giovanni Caforio,Chief Executive Officer, Bristol-Myers Squibb (2015-2023); Chairman of the Board (2017-present);Various leadership roles with Bristol-Myers Squibb (2000-2015).Other Affiliations:Director, Pharmaceutical Research and Manufacturers of America.Stryker Board Committees:Compensation and Human Capital;Governance and Nominating. - Giovanni Caforio,百时美施贵宝首席执行官(2015-2023);董事会主席(2017年至今);Bristol-Myers Squibb的各种领导职务(2000年至2015年)。其他职务:美国制药研究和制造商协会董事。Stryker Corporation董事会委员会:薪酬和人力资本;治理和提名。
- Giovanni Caforio,Chief Executive Officer, Bristol-Myers Squibb (2015-2023); Chairman of the Board (2017-present);Various leadership roles with Bristol-Myers Squibb (2000-2015).Other Affiliations:Director, Pharmaceutical Research and Manufacturers of America.Stryker Board Committees:Compensation and Human Capital;Governance and Nominating.
- Sherilyn S. McCoy
-
Sherilyn S. McCoy ,1982年加入本公司担任公司子公司Personal Products Company研发助理。1995年,她被提名为本公司McNEIL-PPC, Inc.个人产品全球分支机构研发副主席。2000年担任其皮肤护理系列市场营销副总裁。2002年,McCoy女士成为其婴儿及伤口护理系列全球总裁。2005年,她被提名为本公司子公司Ethicon, Inc.公司集团主席和全球特许经营主席。2008年,她成为Surgical Care Group执行委员会成员和全球主席。2009年,她成为Pharmaceuticals Group全球主席。2011年1月,McCoy女士被任命为执行委员会副主席。
Sherilyn S. McCoy,Chief Executive Officer and Director of Avon Products, Inc., a personal care products company, from 2012 to 2018;Had a 30-year career at Johnson & Johnson, where she rose to Vice Chairman in 2011:Most recently at Johnson & Johnson, oversaw Pharmaceutical, Consumer, Corporate Office of Science & Technology, and Information Technology divisions,Served in a number of leadership roles, including Worldwide Chairman, Pharmaceuticals Group from 2009 to 2011; Worldwide Chairman, Surgical Care Group from 2008 to 2009; and Company Group Chairman and Worldwide Franchise Chairman of Ethicon, Inc., a subsidiary of Johnson & Johnson, from 2005 to 2008,Earlier in her career, Ms. McCoy was Global President of the Baby and Wound Care franchise; Vice President, Marketing for a variety of global brands; and Vice President, Research & Development for the Personal Products Worldwide Division. - Sherilyn S. McCoy ,1982年加入本公司担任公司子公司Personal Products Company研发助理。1995年,她被提名为本公司McNEIL-PPC, Inc.个人产品全球分支机构研发副主席。2000年担任其皮肤护理系列市场营销副总裁。2002年,McCoy女士成为其婴儿及伤口护理系列全球总裁。2005年,她被提名为本公司子公司Ethicon, Inc.公司集团主席和全球特许经营主席。2008年,她成为Surgical Care Group执行委员会成员和全球主席。2009年,她成为Pharmaceuticals Group全球主席。2011年1月,McCoy女士被任命为执行委员会副主席。
- Sherilyn S. McCoy,Chief Executive Officer and Director of Avon Products, Inc., a personal care products company, from 2012 to 2018;Had a 30-year career at Johnson & Johnson, where she rose to Vice Chairman in 2011:Most recently at Johnson & Johnson, oversaw Pharmaceutical, Consumer, Corporate Office of Science & Technology, and Information Technology divisions,Served in a number of leadership roles, including Worldwide Chairman, Pharmaceuticals Group from 2009 to 2011; Worldwide Chairman, Surgical Care Group from 2008 to 2009; and Company Group Chairman and Worldwide Franchise Chairman of Ethicon, Inc., a subsidiary of Johnson & Johnson, from 2005 to 2008,Earlier in her career, Ms. McCoy was Global President of the Baby and Wound Care franchise; Vice President, Marketing for a variety of global brands; and Vice President, Research & Development for the Personal Products Worldwide Division.
高管简历
中英对照 |  中文 |  英文- Kevin A. Lobo
Kevin A. Lobo,自2014年7月起担任Stryker Corporation(医疗技术)董事会主席,自2012年10月起担任首席执行官、总裁兼董事。此前,他曾担任Stryker的骨科、神经技术和脊柱集团总裁。Lobo曾担任上述高级领导职务,并在全球公司(包括公开交易的医疗技术和消费品公司)担任其他各种上市公司的领导职务。
Kevin A. Lobo,has been Chairman of the Board of Stryker Corporation (medical technologies) since July 2014 and has been Chief Executive Officer, President and a Director since October 2012. He previously served as Group President for Stryker's Orthopedics and Neurotechnology and Spine Groups.Mr. Lobo has held the senior leadership positions noted above and other various public company leadership roles in global companies, including publicly traded medical technology and consumer products companies.- Kevin A. Lobo,自2014年7月起担任Stryker Corporation(医疗技术)董事会主席,自2012年10月起担任首席执行官、总裁兼董事。此前,他曾担任Stryker的骨科、神经技术和脊柱集团总裁。Lobo曾担任上述高级领导职务,并在全球公司(包括公开交易的医疗技术和消费品公司)担任其他各种上市公司的领导职务。
- Kevin A. Lobo,has been Chairman of the Board of Stryker Corporation (medical technologies) since July 2014 and has been Chief Executive Officer, President and a Director since October 2012. He previously served as Group President for Stryker's Orthopedics and Neurotechnology and Spine Groups.Mr. Lobo has held the senior leadership positions noted above and other various public company leadership roles in global companies, including publicly traded medical technology and consumer products companies.
- William E. Berry Jr.
William E. Berry Jr.在2014年2月被任命为副总裁、公司财务总监和首席会计官。Berry先生监督全球会计和财务职能,并负责内部报告和合并,SEC和外部报告、财务会计研究、政策和程序,以及公司的财务培训和发展计划。Berry先生于2011年8月加入Stryker,担任公司财务总监。在此之前,他曾担任Whirlpool Corporation(一家大型家用器具的世界领先全球制造商和销售商,带领多国公司的会计和报告职能)的助理企业主管。2007至2009年,Berry先生担任Delphi Automotive LLP(一家全球领先的全球汽车零部件制造商)电子与安全事业部的主管。1995年至2007年,Berry先生担任职Federal-Mogul Corporation(一家汽车和工业产品的全球领先供应商);在他的12年任期内,他担任越来越重要的各种职务,最近担任Global Powertrain的财务总监,在此之前,担任总部设在德国的欧洲和南非企业财务总监。Berry 先生在 Deloitte & Touche LLP的公共会计开始他的职业生涯。他获得Eastern Michigan University会计的工商管理学士学位,是一名注册会计师,注册会计师美国研究所的一员。
William E. Berry Jr. was named Vice President, Corporate Controller and Principal Accounting Officer in February 2014. Mr. Berry has oversight responsibility for the global accounting and financial functions and is responsible for internal reporting and consolidations, SEC and external reporting, financial accounting research, policies and procedures and the company's finance training and development programs. Mr. Berry joined Stryker in August 2011 as Corporate Controller. Prior to that, he served as the Assistant Corporate Controller for Whirlpool Corporation the world's leading global manufacturer and marketer of major home appliances leading the accounting and reporting functions for the multi-national company. From 2007 to 2009 Mr. Berry served as the Controller of the Electronics and Safety Division of Delphi Automotive LLP, a leading global vehicle components manufacturer. From 1995 to 2007 Mr. Berry served Federal-Mogul Corporation, a leading global supplier of vehicle and industrial products, and during his 12-year tenure he held various positions of increasing responsibility most recently as the Director of Finance for Global Powertrain and prior to that while based in Germany as the Director of Corporate Finance for Europe and South Africa. Mr. Berry began his career in public accounting at Deloitte & Touche LLP. He earned a Bachelor's of Business Administration degree in accounting from Eastern Michigan University, is a Certified Public Accountant and a member of the American Institute of Certified Public Accountants.- William E. Berry Jr.在2014年2月被任命为副总裁、公司财务总监和首席会计官。Berry先生监督全球会计和财务职能,并负责内部报告和合并,SEC和外部报告、财务会计研究、政策和程序,以及公司的财务培训和发展计划。Berry先生于2011年8月加入Stryker,担任公司财务总监。在此之前,他曾担任Whirlpool Corporation(一家大型家用器具的世界领先全球制造商和销售商,带领多国公司的会计和报告职能)的助理企业主管。2007至2009年,Berry先生担任Delphi Automotive LLP(一家全球领先的全球汽车零部件制造商)电子与安全事业部的主管。1995年至2007年,Berry先生担任职Federal-Mogul Corporation(一家汽车和工业产品的全球领先供应商);在他的12年任期内,他担任越来越重要的各种职务,最近担任Global Powertrain的财务总监,在此之前,担任总部设在德国的欧洲和南非企业财务总监。Berry 先生在 Deloitte & Touche LLP的公共会计开始他的职业生涯。他获得Eastern Michigan University会计的工商管理学士学位,是一名注册会计师,注册会计师美国研究所的一员。
- William E. Berry Jr. was named Vice President, Corporate Controller and Principal Accounting Officer in February 2014. Mr. Berry has oversight responsibility for the global accounting and financial functions and is responsible for internal reporting and consolidations, SEC and external reporting, financial accounting research, policies and procedures and the company's finance training and development programs. Mr. Berry joined Stryker in August 2011 as Corporate Controller. Prior to that, he served as the Assistant Corporate Controller for Whirlpool Corporation the world's leading global manufacturer and marketer of major home appliances leading the accounting and reporting functions for the multi-national company. From 2007 to 2009 Mr. Berry served as the Controller of the Electronics and Safety Division of Delphi Automotive LLP, a leading global vehicle components manufacturer. From 1995 to 2007 Mr. Berry served Federal-Mogul Corporation, a leading global supplier of vehicle and industrial products, and during his 12-year tenure he held various positions of increasing responsibility most recently as the Director of Finance for Global Powertrain and prior to that while based in Germany as the Director of Corporate Finance for Europe and South Africa. Mr. Berry began his career in public accounting at Deloitte & Touche LLP. He earned a Bachelor's of Business Administration degree in accounting from Eastern Michigan University, is a Certified Public Accountant and a member of the American Institute of Certified Public Accountants.
- Yin C. Becker
Yin C. Becker,2012年1月她曾担任讯、公共事务和战略营销副总裁。她领导公司的全球通信、公共事务和企业营销策略的发展和管理,来增强Stryker作为行业领导的地位。在医疗技术行业27年的经验,她的事业涵盖Stryker的几位领导职位。她担任医疗创新副总裁、the Homer Stryker Learning Center的执行董事和Stryker的整形外科的业务的全球通信副总裁。加入Stryker之前,她也担任Pfizer Inc.的各种营销和领导职务10年。她获得Rider University的心理学学士学位。她担任HINJ的副主席和the Ramapo College Board of Governors的成员。
Yin C. Becker was named Vice President, Communications, Public Affairs and Strategic Marketing in January of 2012. Ms. Becker leads the development and management of the company's global communications, public affairs and corporate marketing strategies that enhance Stryker's position as an industry leader. With 27 years of experience in the medical technology industry, Ms. Becker's career spans several senior leadership positions at Stryker. She served as Vice President, Healthcare Innovations, Executive Director of the Homer Stryker Learning Center and Vice President, Global Communications for Stryker's Orthopaedics business. Prior to joining Stryker, Ms. Becker also served for ten years at Pfizer Inc. in various leadership roles in marketing and sales. Ms. Becker holds a B.A. in Psychology from Rider University and she is the Vice Chair for HINJ and a member of the Ramapo College Board of Governors.- Yin C. Becker,2012年1月她曾担任讯、公共事务和战略营销副总裁。她领导公司的全球通信、公共事务和企业营销策略的发展和管理,来增强Stryker作为行业领导的地位。在医疗技术行业27年的经验,她的事业涵盖Stryker的几位领导职位。她担任医疗创新副总裁、the Homer Stryker Learning Center的执行董事和Stryker的整形外科的业务的全球通信副总裁。加入Stryker之前,她也担任Pfizer Inc.的各种营销和领导职务10年。她获得Rider University的心理学学士学位。她担任HINJ的副主席和the Ramapo College Board of Governors的成员。
- Yin C. Becker was named Vice President, Communications, Public Affairs and Strategic Marketing in January of 2012. Ms. Becker leads the development and management of the company's global communications, public affairs and corporate marketing strategies that enhance Stryker's position as an industry leader. With 27 years of experience in the medical technology industry, Ms. Becker's career spans several senior leadership positions at Stryker. She served as Vice President, Healthcare Innovations, Executive Director of the Homer Stryker Learning Center and Vice President, Global Communications for Stryker's Orthopaedics business. Prior to joining Stryker, Ms. Becker also served for ten years at Pfizer Inc. in various leadership roles in marketing and sales. Ms. Becker holds a B.A. in Psychology from Rider University and she is the Vice Chair for HINJ and a member of the Ramapo College Board of Governors.
- M. Kathryn Fink
M. Kathryn Fink在2016年1月被任命为副总裁和首席人力资源官。Fink女士负责所有人力资源政策、做法、计划、方向和活动,包括人才招聘、人才发展、整体薪酬和人力资源共享服务。Fink女士2013年在Stryker开始了她的职业生涯,担任人才管理的副总裁,2015年晋升为MedSurg and Neurotechnology Group人力资源的副总裁。在加盟Stryker之前,她在Cintas Corporation, Ethicon Endo-Surgery(Johnson & Johnson的一个部门)担任过许多范围不断扩大和复杂性的人力资源的职务。Fink女士拥有Kenyon College科学学士学位,和Rutgers'' School of Management and Labor Relations人力资源管理(HRM)的学士学位。
M. Kathryn Fink was named Vice President, Chief Human Resources Officer, in January 2016. Ms. Fink is responsible for all human resources policies, practices, planning, direction and activities, including Talent Acquisition, Talent Development, Total Rewards and HR Shared Services. Ms. Fink began her career with Stryker in 2013 as Vice President, Talent Management and was promoted in 2015 to Vice President, Human Resources, MedSurg and Neurotechnology Group. Prior to joining Stryker, she held a number of HR roles of increasing scope and complexity at Cintas Corporation, Ethicon Endo-Surgery, a division of Johnson & Johnson. Ms. Fink holds a Bachelor of Science degree from Kenyon College and Master''s degree in human resource management (HRM) at Rutgers'' School of Management and Labor Relations.- M. Kathryn Fink在2016年1月被任命为副总裁和首席人力资源官。Fink女士负责所有人力资源政策、做法、计划、方向和活动,包括人才招聘、人才发展、整体薪酬和人力资源共享服务。Fink女士2013年在Stryker开始了她的职业生涯,担任人才管理的副总裁,2015年晋升为MedSurg and Neurotechnology Group人力资源的副总裁。在加盟Stryker之前,她在Cintas Corporation, Ethicon Endo-Surgery(Johnson & Johnson的一个部门)担任过许多范围不断扩大和复杂性的人力资源的职务。Fink女士拥有Kenyon College科学学士学位,和Rutgers'' School of Management and Labor Relations人力资源管理(HRM)的学士学位。
- M. Kathryn Fink was named Vice President, Chief Human Resources Officer, in January 2016. Ms. Fink is responsible for all human resources policies, practices, planning, direction and activities, including Talent Acquisition, Talent Development, Total Rewards and HR Shared Services. Ms. Fink began her career with Stryker in 2013 as Vice President, Talent Management and was promoted in 2015 to Vice President, Human Resources, MedSurg and Neurotechnology Group. Prior to joining Stryker, she held a number of HR roles of increasing scope and complexity at Cintas Corporation, Ethicon Endo-Surgery, a division of Johnson & Johnson. Ms. Fink holds a Bachelor of Science degree from Kenyon College and Master''s degree in human resource management (HRM) at Rutgers'' School of Management and Labor Relations.
- Viju Menon
- 暂无中文简介
暂无英文简介 - 暂无中文简介
- 暂无英文简介
- Robert S. Fletcher
- 暂无中文简介
暂无英文简介 - 暂无中文简介
- 暂无英文简介
- J. Andrew Pierce
- 暂无中文简介
暂无英文简介 - 暂无中文简介
- 暂无英文简介
- Spencer S. Stiles
- 暂无中文简介
暂无英文简介 - 暂无中文简介
- 暂无英文简介
- Preston W. Wells
Preston W. Wells,自2022年7月起担任公司副总裁兼骨科集团首席财务官。在此之前,他曾于2020年6月至2022年7月担任投资者关系副总裁,2016年6月至2020年6月担任财务规划与分析副总裁,并于2015年10月至2016年6月担任财务高级总监。在加入公司之前,Wells先生拥有17年的会计和财务管理经验,曾在Dialight Corporation和强生担任财务领导职务。Wells先生毕业于巴克内尔大学,获得会计学学士学位,并在利哈伊大学获得供应链管理MBA学位。
Preston W. Wells,has been Vice President, Group Chief Financial Officer of Orthopaedics at the Company since July 2022. Prior to that, he was Vice President, Investor Relations from June 2020 to July 2022, Vice President, Financial Planning & Analysis from June 2016 to June 2020 and Senior Director, Finance from October 2015 to June 2016. Before joining the Company, Mr. Wells had 17 years of accounting and financial management experience, holding finance leadership roles at Dialight Corporation and Johnson & Johnson. Mr. Wells graduated from Bucknell University with a bachelor's degree in accounting and earned an MBA in Supply Chain Management from Lehigh University.- Preston W. Wells,自2022年7月起担任公司副总裁兼骨科集团首席财务官。在此之前,他曾于2020年6月至2022年7月担任投资者关系副总裁,2016年6月至2020年6月担任财务规划与分析副总裁,并于2015年10月至2016年6月担任财务高级总监。在加入公司之前,Wells先生拥有17年的会计和财务管理经验,曾在Dialight Corporation和强生担任财务领导职务。Wells先生毕业于巴克内尔大学,获得会计学学士学位,并在利哈伊大学获得供应链管理MBA学位。
- Preston W. Wells,has been Vice President, Group Chief Financial Officer of Orthopaedics at the Company since July 2022. Prior to that, he was Vice President, Investor Relations from June 2020 to July 2022, Vice President, Financial Planning & Analysis from June 2016 to June 2020 and Senior Director, Finance from October 2015 to June 2016. Before joining the Company, Mr. Wells had 17 years of accounting and financial management experience, holding finance leadership roles at Dialight Corporation and Johnson & Johnson. Mr. Wells graduated from Bucknell University with a bachelor's degree in accounting and earned an MBA in Supply Chain Management from Lehigh University.
- Dylan Crotty
Dylan Crotty,自2018年起担任仪器公司总裁。在公司27年的职业生涯中,Crotty先生在MedSurg和Neurotechnology以及Trauma & Extremities和欧洲担任过领导职务。Crotty先生毕业于Hope学院,获得工商管理学士学位。
Dylan Crotty,has served as President, Instruments since 2018. Throughout his 27-year career at the Company, Mr. Crotty has held leadership roles across MedSurg and Neurotechnology as well as Trauma & Extremities and Europe. Mr. Crotty graduated from Hope College with a bachelor's degree in business administration.- Dylan Crotty,自2018年起担任仪器公司总裁。在公司27年的职业生涯中,Crotty先生在MedSurg和Neurotechnology以及Trauma & Extremities和欧洲担任过领导职务。Crotty先生毕业于Hope学院,获得工商管理学士学位。
- Dylan Crotty,has served as President, Instruments since 2018. Throughout his 27-year career at the Company, Mr. Crotty has held leadership roles across MedSurg and Neurotechnology as well as Trauma & Extremities and Europe. Mr. Crotty graduated from Hope College with a bachelor's degree in business administration.